CAH-X: Congenial adrenal hyperplasia with EDS

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/1000000355
• EU PAS number:
  EUPAS1000000355
• Study ID:
  1000000355
• Official title and acronym:
  CAH-X: Congenial adrenal hyperplasia with EDS
• DARWIN EU® study:
  No
• Study countries:
  Austria
• Study status:
  Planned

Research institutions and networks

Institutions

Medical University of Vienna

Austria

Study timelines

Date when funding contract was signed

Planned: 01/12/2024

Study start date

Planned: 01/04/2025

Data analysis start date

Planned: 01/04/2026

Date of final study report

Planned: 31/03/2028

Sources of funding

National competent authority (NCAs)

More details on funding

Austrian Science Fund (FWF)

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable